{
    "2020-12-21": [
        [
            {
                "time": "",
                "original_text": "长春高新股东金磊减持409万股，套现超15亿元，减持股份",
                "features": {
                    "keywords": [
                        "长春高新",
                        "金磊",
                        "减持",
                        "套现"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "生长激素企业玩“跨界”，长春高新CD47抗体在美国获批临床",
                "features": {
                    "keywords": [
                        "长春高新",
                        "CD47抗体",
                        "美国",
                        "临床试验",
                        "跨界"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：医保谈判靴子落地，迎接创新驱动的核心资产景气回归",
                "features": {
                    "keywords": [
                        "医药行业",
                        "医保谈判",
                        "创新",
                        "核心资产",
                        "景气回归"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：如何选股？创新赋能、制造升级和降本增效",
                "features": {
                    "keywords": [
                        "医药行业",
                        "选股",
                        "创新赋能",
                        "制造升级",
                        "降本增效"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "机构持仓百亿元以上，这些医药龙头为何被偏爱？",
                "features": {
                    "keywords": [
                        "机构持仓",
                        "医药龙头",
                        "偏爱"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "第四批药品集采倒计时，医药行业将加速创新转型",
                "features": {
                    "keywords": [
                        "药品集采",
                        "医药行业",
                        "创新转型"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}